Guidance on the use of glycoprotein (GP) IIb/IIIa antagonists in the treatment of acute coronary syndromes

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.385, 2002-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Guidance on the use of glycoprotein (GP) IIb/IIIa antagonists in the treatment of acute coronary syndromes

By  

Inpharma, Vol. 1, Iss. 1357, 2002-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

GP IIb/IIIa receptor antagonists beneficial in acute coronary syndromes

By  

Inpharma, Vol. 1, Iss. 1221, 2000-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

The therapeutic use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes

By Manoharan G.   Maynard S.J.   Adgey A.J.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 5, 1999-05 ,pp. : 555-566

Informa Healthcare

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes

By  

Heart Drug, Vol. 1, Iss. 2, 2004-11 ,pp. : 103-109

Karger

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Receptor Antagonists in Non-ST Elevation Acute Coronary Syndromes and Percutaneous Revascularisation: A Review of Trial Reports

By Kong D.F.  

Drugs, Vol. 58, Iss. 4, 1999-10 ,pp. : 609-620

Adis International

Access to resources Recommend Favorite